Clinical Trials Sponsored by HitGen Inc.

Total 36305 results

HitGen Inc.

Recruiting

A Study of HG381 Administered to Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
HitGen Inc.

Recruiting

Clinical Trial of HG146 Administered to Subjects With Advanced Solid Tumors or Lymphoma

Lymphoma | Solid Tumor

China
HitGen Inc.

Terminated

A Study of HG146 Capsule in Chinese Subjects With Relapsed and Refractory Multiple Myeloma

Multiple Myeloma | Relapsed and Refractory Multiple Myeloma

China
QIAGEN Gaithersburg, Inc

Recruiting

Clinical Performance Evaluation of the NeuMoDx™ FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 Assay

Respiratory Disease

United Kingdom
QIAGEN Gaithersburg, Inc

Completed

QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study

Meningitis/Encephalitis

United Kingdom
Biogen
Alkermes, Inc.

Completed

A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2

Relapsing Remitting Multiple Sclerosis

United States, Germany, Poland
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the QuantiFERON-TB Test.

Tuberculosis

United States
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection

Tuberculosis

United States
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the QuantiFERON-TB Test.

Tuberculosis

United States
Genentech, Inc.
Biogen

Completed

A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis (SUNDIAL)

Rheumatoid Arthritis
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the Artus® CMV PCR Test (CMV)

Cytomegalovirus Infections

United States
QIAGEN Gaithersburg, Inc

Terminated

Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People (QFM)

HIV Positive

United States
QIAGEN Gaithersburg, Inc

Recruiting

Clinical Evaluation of the NeuMoDx SARS-CoV-2 Assay (COVID-19)

SARS-CoV-2 Acute Respiratory Disease

United Kingdom
QIAGEN Gaithersburg, Inc

Not yet recruiting

QIAstat-Dx® BCID Plus AMR Panels Clinical Performance Study

Blood Disease
QIAGEN Gaithersburg, Inc

Active, not recruiting

QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study

Meningitis/Encephalitis

United Kingdom
Eisai Inc.
Biogen

Active, not recruiting

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease (Clarity AD)

Early Alzheimer's Disease

United States, Spain, Korea, Republic of, China, United Kingdom, Australia, Canada, France, Germany, Italy, Japan, Russian Federation, Singapore, Sweden
Eisai Inc.
Biogen

Terminated

Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease

Alzheimer Disease | Dementia, Alzheimer Type

United States
QIAGEN Gaithersburg, Inc

Withdrawn

QuantiFERON Access Clinical Performance Study Protocol

Tuberculosis (TB)
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the QuantiFERON-TB Test.

Tuberculosis

United States
Quintiles, Inc.
Biogen

Completed

A Validation Study of the Novel Application of Telehealth in Clinical Drug Development in Subjects With Mild Cognitive Deficits (REINVENT)

Mild Cognitive Impairment | Alzheimer's Disease

United States
QIAGEN Gaithersburg, Inc

Terminated

Clinical Evaluation of the AmniSure ROM Test

Rupture of Fetal Membranes

United States
QIAGEN Gaithersburg, Inc

Terminated

Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients

Cell-mediated Immune Response

United States
Genentech, Inc.
Biogen

Completed

A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE) (SUNSTONE)

Rheumatoid Arthritis

United States, Puerto Rico
QIAGEN Gaithersburg, Inc

Completed

Collection and Extraction of Respiratory Specimens

Influenza

United States
QIAGEN Gaithersburg, Inc

Completed

QIAstat-Dx® Respiratory Panel Plus (RPP) Clinical Performance Study

Respiratory Disease

United Kingdom
Biogen
Apple Inc.

Terminated

An Observational Study Using Multimodal Sensors to Measure Cognitive Health in Adults and Distinguish Mild Cognitive Impairment From Normal Aging (Intuition)

Mild Cognitive Impairment | Normal Aging

United States
Eisai Inc.
Biogen

Active, not recruiting

A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease

Alzheimer's Disease

United States, Canada, France, Germany, Italy, Japan, Korea, Republic of, Netherlands, Spain, Sweden, United Kingdom
Biogen
Alkermes, Inc.

Completed

A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1

Multiple Sclerosis

United States, Bulgaria, Poland, Belgium, Canada, Germany, Russian Federation, Serbia, Spain, Ukraine
QIAGEN Gaithersburg, Inc

Terminated

Clinical Evaluation of the QuantiFERON CMV Assay

CMV

United States
QIAGEN Gaithersburg, Inc

Completed

Collection and Testing of Respiratory Samples

Respiratory Syncytial Virus Infections | Influenza A | Rhinovirus | Influenza B | QIAGEN ResPlex II Advanced Panel | Infection Due to Human Parainfluenza Virus 1 | Parainfluenza Type 2 | Parainfluenza Type 3 | Parainfluenza Type 4 | Human Metapneumovirus A/B | Coxsackie Virus/Echovirus | Adenovirus Types B/C/E | Coronavirus Subtypes 229E and other conditions

United States
Biogen
Ionis Pharmaceuticals, Inc.

Active, not recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease (REASON)

Parkinson's Disease

United States, Spain, Israel, Canada, Norway, United Kingdom
Biogen
Ionis Pharmaceuticals, Inc.

Active, not recruiting

Long-Term Evaluation of BIIB067 (Tofersen)

ALS Caused by Superoxide Dismutase 1 (SOD1) Mutation

United States, Canada, Italy, Belgium, New Zealand, Japan, France, Germany, United Kingdom
Biogen
Denali Therapeutics Inc.

Completed

A Study to Determine the Absolute Bioavailability of BIIB122/DNL151 in Healthy Subjects

Healthy Volunteers

United States
ATGen Canada Inc

Terminated

Analysis of Natural Killer Cell Activity (NKA) in Whole Blood in High Risk Subjects Undergoing Colonoscopy (ANKA-HR)

Colorectal Cancer | Immunity, Innate

Canada
ATGen Canada Inc

Terminated

Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy (ANKA-PCA)

Prostatic Neoplasm | Immunity, Innate

Canada
Alcyone Therapeutics, Inc
Biogen

Recruiting

Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy (PIERRE)

Scoliosis | Spinal Muscular Atrophy | Spine Deformity

United States
QIAGEN Gaithersburg, Inc
Amgen

Recruiting

Therascreen® KRAS RGQ PCR Kit

Colo-rectal Cancer

United Kingdom
Ionis Pharmaceuticals, Inc.
Biogen

Active, not recruiting

HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome

Angelman Syndrome

United States, Israel, Italy, France, Australia, United Kingdom
Biogen
Ionis Pharmaceuticals, Inc.

Completed

An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 (Tofersen) in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C))

Amyotrophic Lateral Sclerosis

United States, Canada, Belgium, France, Australia, Japan, Denmark, Korea, Republic of, United Kingdom, Germany, Italy, Poland
QIAGEN Gaithersburg, Inc
Amgen

Active, not recruiting

Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit

Non-small Cell Lung Cancer

United Kingdom
QIAGEN Gaithersburg, Inc
Amgen

Active, not recruiting

Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit

Colorectal Cancer | Non-Small Cell Lung Cancer

United Kingdom
Astellas Pharma Inc
Biogen

Completed

A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis

Psoriatic Arthritis

Poland, Canada, United States, Russian Federation, Germany
Astellas Pharma Inc
Biogen

Completed

Community Based Trial for AMEVIVE®

Moderate to Severe Chronic Plaque Psoriasis

United States
Astellas Pharma Inc
Biogen

Completed

A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate

Chronic Plaque Psoriasis

United States, Austria, Germany, Belgium, Canada
Hinge Health, Inc

Active, not recruiting

HFIT Versus TENS Study for Chronic Low Back and Knee Pain

Chronic Pain | Knee Pain Chronic | Back Pain, Low

United States
Biogen
Denali Therapeutics Inc.

Recruiting

A Study to Assess the Safety of BIIB122 Tablets and if it Can Slow the Worsening of Early-Stage Parkinson's Disease in Participants Between the Ages of 30 and 80 (LUMA)

Parkinson Disease

United States, Netherlands, Italy, Spain, Israel, Canada, China, Germany, France, Austria, United Kingdom, Poland, Japan
Biogen
Denali Therapeutics Inc.

Terminated

A Study to Assess if BIIB122 Tablets Are Safe and Can Slow Worsening of Early-Stage Parkinson's Disease in Participants With Specific LRRK2 Genetic Variants Between the Ages of 30 and 80 Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (LIGHTHOUSE)

Parkinson Disease

United States, Italy, Spain, Germany, France, United Kingdom
QIAGEN Gaithersburg, Inc
Amgen

Active, not recruiting

Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit

Non Small Cell Lung Cancer

United Kingdom
Biogen
Denali Therapeutics Inc.

Completed

A Study of Mass Balance, Pharmacokinetics, Metabolite Profile, and Metabolite Identification of BIIB122/DNL151 in Healthy Male Subjects

Healthy Volunteers

United States
Astellas Pharma Inc
Biogen

Completed

Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis

Psoriasis

Belgium, Spain, Germany, United States, France, Canada, Denmark, Netherlands, United Kingdom

Clinical Trials Sponsored by HitGen Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations